Cargando…

Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin

Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005).

Detalles Bibliográficos
Autores principales: Chaudhry, Haroon Rashid, Arshad, Nadia, Niaz, Saima, Suleman, Tahir, Mufti, Khalid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Psychiatrists 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734827/
https://www.ncbi.nlm.nih.gov/pubmed/31507951
_version_ 1783450229609070592
author Chaudhry, Haroon Rashid
Arshad, Nadia
Niaz, Saima
Suleman, Tahir
Mufti, Khalid A.
author_facet Chaudhry, Haroon Rashid
Arshad, Nadia
Niaz, Saima
Suleman, Tahir
Mufti, Khalid A.
author_sort Chaudhry, Haroon Rashid
collection PubMed
description Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005).
format Online
Article
Text
id pubmed-6734827
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Royal College of Psychiatrists
record_format MEDLINE/PubMed
spelling pubmed-67348272019-09-10 Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin Chaudhry, Haroon Rashid Arshad, Nadia Niaz, Saima Suleman, Tahir Mufti, Khalid A. Int Psychiatry Original Article Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005). The Royal College of Psychiatrists 2008-07-01 /pmc/articles/PMC6734827/ /pubmed/31507951 Text en © 2008 The Royal College of Psychiatrists http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Chaudhry, Haroon Rashid
Arshad, Nadia
Niaz, Saima
Suleman, Tahir
Mufti, Khalid A.
Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
title Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
title_full Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
title_fullStr Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
title_full_unstemmed Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
title_short Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
title_sort comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734827/
https://www.ncbi.nlm.nih.gov/pubmed/31507951
work_keys_str_mv AT chaudhryharoonrashid comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin
AT arshadnadia comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin
AT niazsaima comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin
AT sulemantahir comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin
AT muftikhalida comparisonofrisperidoneolanzapineandquetiapineeffectsonbodyweightserumbloodglucoseandprolactin